Why supplement?
Marked asPrimarySupporting
Supports fasting triglycerides
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use.
Supports brain and visual membrane lipids
DHA is especially abundant in gray matter and in retinal outer segments, serving as structural lipid that supports fluidity of neuronal and photoreceptor membranes. For people who are pregnant, aging, or who eat little fish long term, this membrane-lipid path more often looks after brain and vision with continued use.
Moderates inflammatory mediators
EPA can compete into eicosanoid paths so the body leans toward milder inflammatory mediators. For people with morning joint swelling or tissue discomfort after exercise, the direction of change on swelling and comfort scales is more often noticeable after several weeks of continued use.
Which symptoms may ease?
Dry eyes
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People whose eyes dry at a screen and who blink constantly more often notice moisture and less foreign-body feeling after several continuous weeks.
Joint pain
EPA can compete into eicosanoid paths so the body leans toward milder inflammatory mediators. People whose knees tighten on stairs and whose joints are stiff on waking more often notice easier movement and a shorter stiff period after several continuous weeks.
Low mood
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People who cannot get going and feel less interest in usual likes more often notice mood-scale scores and daytime interest after several continuous weeks.
Which conditions may it support?
Hypertriglyceridaemia
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People whose triglycerides run clearly high more often notice lipid reports after several continuous weeks.
Coronary heart disease
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People watching heart markers and tightness after activity more often notice labs and activity tolerance after several continuous weeks.
Rheumatoid arthritis
EPA can compete into eicosanoid paths so the body leans toward milder inflammatory mediators. People with morning stiffness in matching small joints, already in rheumatology follow-up, more often notice stiff time and range of motion after several continuous weeks.
Major depressive disorder
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People with fading interest and hard mornings who already track mood scales more often notice support in scores and daytime function after several continuous weeks.
Dry eye disease
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People with an unstable tear film and dry eyes already in eye-clinic follow-up more often notice moisture and less foreign-body feeling after several continuous weeks.
ADHD
After EPA and DHA enter cell-membrane phospholipids, human-trial evidence for a drop in fasting triglycerides is relatively strong. For people who eat little fish and need to manage blood lipids, changes in fasting lipid markers are more often seen along this long-chain path after several weeks of continued use. People who cannot sit through a task and whose attention breaks easily more often notice completion rate and impulse control after several continuous weeks.
How to take it?
After continued use, reassess by how you feel and whether you still need it.
How oftenUsually fine to use daily; adjust to personal need.
What to watch
Cautions
Fish allergy, bleeding tendency, or upcoming surgery: ask a clinician before use.
Interactions
- Anticoagulants / antiplatelets, and before surgery (high-dose EPA+DHA bleeding risk)
· Some people may notice mild digestive or other discomfort.
· If discomfort persists or you worry about drug interactions, seek professional advice.
Long-term dependenceNo typical addiction evidence; do not exceed labeled amounts on your own long term.